-
L01EA : BCR-ABL tyrosine kinase inhibitors
-
L01EB : Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors
-
L01EC : B-Raf serine-threonine kinase (BRAF) inhibitors
-
L01ED : Anaplastic lymphoma kinase (ALK) inhibitors
-
L01EE : Mitogen-activated protein kinase (MEK) inhibitors
-
L01EF : Cyclin-dependent kinase (CDK) inhibitors
-
L01EG : Mammalian target of rapamycin (mTOR) kinase inhibitors
-
L01EH : Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors
-
L01EJ : Janus-associated kinase (JAK) inhibitors
-
L01EK : Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors
-
L01EL : Bruton's tyrosine kinase (BTK) inhibitors
-
L01EM : Phosphatidylinositol-3-kinase (Pi3K) inhibitors
-
L01EN : Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors
-
L01EX : Other protein kinase inhibitors